REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/12/2025
Voltar para busca
Dado oficial do USPTO
DIRECTMX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DIRECTMX
ST13
US500000088614061Classe
1, 5, 40, 42
Pedido
88614061
Registro
6208690
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
02/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
12/09/2019
Data de registro
01/12/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/12/2020
Última transação
02/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Stockholm, SE
Examinador
LE, MARGARET
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SALIPRO BIOTECH AB
Representantes
Timothy P. Naill REINHART BOERNER VAN DEUREN P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biological preparations for use in industry; Biological preparations for use in science; Carriers for biologically active compounds; Biological substancesmaterialspreparations and elements for scientific and industrial use in vivo and in vitro; Chemical substanceschemical materials and chemical preparationsnatural elements for scientific and industrial use in vivo and in vitro; biological materials for use in industry and science; Chemical substancesmaterialspreparations and elements for cosmetic preparations; Biological substancesmaterialspreparations and elements for cosmetic preparations; Lipid nanoparticles for use in industry and science; Lipid nanoparticles comprising protein for use in industry and science; Saposin-lipid nanoparticles for use in industry and science
Classe 5
Biochemical preparations for preventing or treating infectious or parasitic diseasescancerdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eyediseases of the eardiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary system and autoimmune diseases; Biochemical preparations for preventing or treating infectious or parasitic diseasescancerdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eyediseases of the eardiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary system and autoimmune diseases in non-human animals; Biological reagents for medical use; Biological reagents for veterinary use; Carriers for pharmaceuticalmedicalveterinary or diagnostic compounds; Biochemical preparations for preventing or treating infectious or parasitic diseasescancerdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eyediseases of the eardiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary system and autoimmune diseases in humans and non-human animals and for use in a diagnostic method; Medicinal preparations and substances for preventing or treating infectious or parasitic diseasescancerdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eyediseases of the eardiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary system and autoimmune diseases in humans and non-human animals; Veterinary vaccines; Human vaccine preparations; Lipid nanoparticles for medicinaldiagnostic or pharmaceutical purposes; Lipid nanoparticles comprising protein for medicaldiagnostic or pharmaceutical purposes; Saposin-lipid nanoparticles for medicaldiagnostic or pharmaceutical purposes
Classe 40
Treatment of cells and/or viruses and/or biological membranes to obtain carriers for biologically activepharmaceutical or diagnostic compounds; Conversion of cells and/or viruses and/or biological membranes into biochemical preparations; Custom manufacturing of lipid nanoparticles in particular of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles; Processing of cells and/or viruses and/or biological membranes for third parties
Classe 42
Biological laboratory services; Biochemistry consultancy; Consulting services in the field of lipid nanoparticles in particular in the field of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/09/2020
PUBO
PUBLISHED FOR OPPOSITION
15/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/08/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/08/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/08/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/08/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
24/06/2020
GNSL
LETTER OF SUSPENSION E-MAILED
24/06/2020
CNSL
SUSPENSION LETTER WRITTEN
24/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/06/2020
ALIE
ASSIGNED TO LIE
15/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/12/2019
GNRT
NON-FINAL ACTION E-MAILED
19/12/2019
CNRT
NON-FINAL ACTION WRITTEN
19/12/2019
DOCK
ASSIGNED TO EXAMINER
13/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/09/2019
NWAP
NEW APPLICATION ENTERED
16/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DIRECTMX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.